Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities

Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), Zhi‐Ming Shao(Shanghai Medical College of Fudan University), Lei-Jie Dai(Fudan University Shanghai Cancer Center), Yuanting Zheng(Fudan University), Nakul M. Shah(James S. McDonnell Foundation), Weigang Ge, Wentao Yang(Fudan University Shanghai Cancer Center), Anneleen Daemen, Guan-Hua Su(Fudan University Shanghai Cancer Center), Qingwang Chen(Fudan University), Wanwan Hou(Fudan University), Leming Shi(Fudan University), Naixin Zhang(Fudan University), Yajia Gu(Fudan University Shanghai Cancer Center), Xi Jin(First Affiliated Hospital Zhejiang University), Virginia Kaklamani(Northwestern University), Yaqing Liu(Fudan University), Jingcheng Yang(Fudan University), Tong‐Ming Fu(Doylestown Hospital), Ding Ma(Shanghai Medical College of Fudan University), Ying Yu(Fudan University), Charles M. Perou(University of North Carolina at Chapel Hill), Cai‐Jin Lin(Shanghai Medical College of Fudan University), Claire F. Verschraegen(The Ohio State University), François Bertucci(Centre National de la Recherche Scientifique), Shen Zhao(Sun Yat-sen University), Yi Xiao(The University of Texas Southwestern Medical Center), Ting Wang(Wenzhou Medical University), Wei Liu(Chuxiong Normal University), Wenjuan Zhang(Fudan University Shanghai Cancer Center), Jinxiu Shi, Chenglin Liu(Shanghai Medical College of Fudan University), Yi-Fan Zhou(Shanghai Medical College of Fudan University), Tiannan Guo(Westlake University), Wei Huang(Chinese National Human Genome Center), Chao You(Shenzhen Children's Hospital)
Nature Cancer
February 12, 2024
Cited by 85


Related Papers